Assenagon Asset Management
EBS icon

Assenagon Asset Management’s Emergent Biosolutions EBS Stock Holding History

Assenagon Asset Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$473K Hold
56,455
– – ﹤0.01% 1076
2026
Q1 		$469K Sell
56,455
-1,350
-2% -$14K ﹤0.01% 1013
2025
Q4 		$714K Buy
57,805
+1,350
+2% +$14.5K ﹤0.01% 1011
2025
Q3 		$498K Sell
56,455
-253,236
-82% -$1.97M ﹤0.01% 1055
2025
Q2 		$1.98M Sell
309,691
-235,876
-43% -$1.35M ﹤0.01% 775
2025
Q1 		$2.65M Sell
545,567
-220,970
-29% -$1.83M ﹤0.01% 680
2024
Q4 		$7.33M Buy
766,537
+24,985
+3% +$229K 0.01% 592
2024
Q3 		$6.19M Buy
741,552
+316,700
+75% +$2.88M 0.01% 655
2024
Q2 		$2.9M Sell
424,852
-414,562
-49% -$1.78M 0.01% 788
2024
Q1 		$2.12M Buy
839,414
+5,042
+0.6% +$11.4K 0.01% 874
2023
Q4 		$2M Buy
834,372
+651,480
+356% +$1.53M 0.01% 929
2023
Q3 		$622K Buy
182,892
+87,654
+92% +$486K ﹤0.01% 1161
2023
Q2 		$700K Buy
+95,238
New +$883K ﹤0.01% 1059
2023
Q1 		– Sell
-59,007
Closed -$697K – 1435
2022
Q4 		$697K Buy
59,007
+14,645
+33% +$227K ﹤0.01% 1119
2022
Q3 		$931K Sell
44,362
-94,954
-68% -$2.64M ﹤0.01% 944
2022
Q2 		$4.32M Buy
139,316
+80,223
+136% +$2.74M 0.02% 590
2022
Q1 		$2.43M Sell
59,093
-92,330
-61% -$4.07M 0.01% 758
2021
Q4 		$6.58M Buy
151,423
+116,297
+331% +$5.26M 0.02% 443
2021
Q3 		$1.76M Buy
35,126
+8,832
+34% +$535K 0.01% 743
2021
Q2 		$1.66M Buy
+26,294
New +$1.69M 0.01% 745
2020
Q4 		– Sell
-19,600
Closed -$2.02M – 1076
2020
Q3 		$2.02M Buy
+19,600
New +$2.11M 0.01% 581
2019
Q4 		– Sell
-15,810
Closed -$827K – 813
2019
Q3 		$827K Buy
+15,810
New +$737K 0.01% 591
2019
Q1 		– Sell
-24,443
Closed -$1.45M – 982
2018
Q4 		$1.45M Buy
+24,443
New +$1.58M 0.02% 551

Other funds holding EBS

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
BWM
Baron Wealth Management Troy, Michigan $386M AUM 30.18% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MFT
Moisand Fitzgerald Tamayo Orlando, Florida $1.02B AUM 21.26% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
TM
Torren Management San Diego, California $197M AUM

Assenagon Asset Management's EBS Position: Q2 2026 in Review

Assenagon Asset Management held its Emergent Biosolutions (EBS) position steady in Q2 2026 at 56,455 shares worth $473K. The position accounts for ﹤0.01% of the portfolio, ranked #1076.

Assenagon Asset Management first reported a position in EBS in Q4 2018 and has held it in 23 quarters since. The position peaked at $7.33M in Q4 2024. 14 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Assenagon Asset Management held 56,455 shares of Emergent Biosolutions worth $473K as of Q2 2026.
  • Assenagon Asset Management left its Emergent Biosolutions share count unchanged in Q2 2026.
  • Emergent Biosolutions made up ﹤0.01% of Assenagon Asset Management's portfolio in Q2 2026, its #1076 holding.
  • Assenagon Asset Management first reported a position in Emergent Biosolutions in Q4 2018 and has held it in 23 quarters since.
  • Assenagon Asset Management's Emergent Biosolutions position peaked at $7.33M in Q4 2024.
  • 14 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.